Immunology · 2005 · 41 citations · 56 references
Life SciencesImmunologyPharmacologyCellular ImmunologyImmunoregulationImmunotherapyCell-mediated ImmunityHuman Leukocyte Antigen SystemNatural Killer Cell BiologyT Cell ActivationT Cell BiologyT Cell ToleranceHla-g Mediated Immune ModulationHla-g Mediated Immune RegulationHla-g-mediated Immune ModulationHuman Leukocyte Antigen-g ExpressionHuman Leukocyte AntigensIndoleamine 2, 3-Dioxygenase PathwayNonclassical Hla MoleculesT-cell Regulation
Both human leucocyte antigen (HLA)-G and indoleamine 2,3 dioxygenase (IDO) are key molecules involved in immune tolerance. HLA-G is a non-classical HLA class I molecule that can be expressed in both membrane-bound (HLA-G1) and soluble (HLA-G5) forms, both of which exhibit tolerogenic properties via interaction with inhibitory receptors present on natural killer (NK) cells, T cells and antigen-presenting cells (APC). IDO is an enzyme that acts by depleting the surrounding microenvironment of the essential amino acid, tryptophan, thereby inhibiting T-cell proliferation. Our present study was aimed at analysing the potential link that may exist between IDO and HLA-G. Our results showed that during allogeneic reactions, soluble HLA-G expression was not regulated by the addition of IDO substrate (i.e. tryptophan), metabolite (i.e. kynurenine) or inhibitor (i.e. 1-methyl-tryptophan), that IDO activity was not altered by HLA-G5 treatment, and that HLA-G5-mediated inhibition of the T-cell alloproliferative response was neither affected by the presence of tryptophan and kynurenine nor reversed after IDO activity blockage, demonstrating that HLA-G5 can exert its function in the absence of functional IDO. Similarly, inhibition of the T-cell alloresponse, induced by HLA-G1-expressing antigen-presenting cells, was not altered by IDO metabolites or inhibitor. Taken together, these findings show that the function and expression of IDO and HLA-G5 are not mutually influenced, but rather inhibit the T-cell alloproliferative response through two independent pathways. IDO and HLA-G are thus complementary for inducing and maintaining immune tolerance in physiological (pregnancy) and pathological (tumour and allograft) situations.
56
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
David H. Munn, Min Zhou, John T. Attwood et al. · Science · 1998 · 2.6K citations
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
David H. Munn, Ebrahim Shafizadeh, John T. Attwood et al. · The Journal of Experimental Medicine · 1999 · 1.6K citations · Full text
Guido Frumento, Rita Rotondo, Michela Tonetti et al. · The Journal of Experimental Medicine · 2002 · 1.1K citations · Full text
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
David H. Munn, Madhav Sharma, Jeffrey R. Lee et al. · Science · 2002 · 1K citations